Effect of body mass index (BMI) on response to neoadjuvant therapy in human epidermal growth factor receptor 2 (HER2) positive breast cancer (BC): Analysis from NeoALLTO trial Meeting Abstract


Authors: Galli, G.; Bradbury, I.; Cinieri, S.; Agbor-Tarh, D.; De Braud, F. G. M.; Baselga, J.; Huober, J.; Fumagalli, D.; Sarp, S.; Piccart, M.; de Azambuja, E.; Di Cosimo, S.
Abstract Title: Effect of body mass index (BMI) on response to neoadjuvant therapy in human epidermal growth factor receptor 2 (HER2) positive breast cancer (BC): Analysis from NeoALLTO trial
Meeting Title: 41st European Society for Medical Oncology Congress (ESMO)
Journal Title: Annals of Oncology
Volume: 27
Issue: Suppl. 6
Meeting Dates: 2016 Oct 7-11
Meeting Location: Copenhagen, Denmark
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2016-10-01
Start Page: vi57
Language: English
ACCESSION: WOS:000393912500190
DOI: 10.1093/annonc/mdw364.47
PROVIDER: wos
Notes: Meeting Abstract: 191P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jose T Baselga
    484 Baselga